Hepatitis C is a disease that affects the liver. Living with hepatitis C for a long time can damage your liver to the point where it doesn’t work very well. Early treatment can help protect your liver ...

Hepatitis C is a type of blood-borne virus that targets the liver, causing inflammation and liver damage if untreated. It spreads between people by blood-to-blood contact. In cases covered by the ...

Hepatitis C treatments are highly effective at reaching remission. A person in hepatitis C remission has no detectable amounts of the virus in their blood 12 or 24 weeks after their last treatment.

Hepatitis refers to any inflammation of the liver caused by five different viruses: hepatitis A, B, C, D, and E. The best way you can prevent hepatitis is to stay up ...

Hepatitis C and cirrhosis of the liver are medical conditions that can damage and inflame the liver. Cirrhosis is scarring of the liver that can occur from hepatitis C and other conditions. Both ...

Although medication can cure hepatitis C, millions of people aren’t taking it. Problem is, if the virus isn’t treated, it can cause serious health complications. There’s a reason the hepatitis C virus ...

Hepatitis C is the leading blood borne infection, and the number one cause of liver disease in the United States. The Center for Disease Control estimates that 2.7 million people in the US are ...

Medications for hepatitis C vary based on the virus’s genotype and the amount of liver scarring a person has, making it crucial to identify the specific genotype for effective treatment. Combination ...

An estimated 2.7 to 3.9 million people in the United States have chronic hepatitis C, according to the National Institute of Diabetes and Digestive and Kidney Diseases, and more than half are not ...

For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These drugs, ...

Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval. By Ted Alcorn In the 10 years since ...